Keyphrases
Acute Withdrawal
16%
Adrenergic Receptor Agonists
16%
Adrenergic Receptor Antagonist
16%
Adrenergic Receptors
33%
Adrenergic Stimulation
16%
Affective Factors
16%
Brain Reward System
33%
Brain Stimulation Reward
100%
Central Amygdala
100%
Clonidine
16%
Corticotropin-releasing Factor
16%
CRF1 Receptor
100%
CRF1 Receptor Antagonist
33%
Discrete Trials
16%
Dysphoria
100%
Intracranial Self-stimulation
16%
Mecamylamine
50%
Minipump
16%
Negative Mood States
16%
Nicotine
66%
Nicotine Dependence
16%
Nicotine Withdrawal
100%
Nicotinic Acetylcholine Receptor (nAChR)
16%
Noradrenergic
16%
Prazosin
16%
Receptor Blockade
16%
Reward Thresholds
100%
Sigma-1 Receptor
16%
Smokers
16%
Smoking Cessation
33%
Withdrawal Phase
16%
Withdrawal Syndrome
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenergic Receptor
66%
Adrenergic Receptor Blocking Agent
33%
Adrenergic Receptor Stimulating Agent
33%
Clonidine
33%
Corticotropin Releasing Factor
33%
Dysphoria
100%
Mecamylamine
100%
Nicotinic Acetylcholine Receptor Antagonist
33%
Prazosin
33%
Receptor
100%
Receptor Antagonist
66%
Sigma 1 Opiate Receptor
33%
Tobacco Dependence
33%
Withdrawal Syndrome
33%
Neuroscience
Adrenergic Receptor
50%
Adrenergic Stimulation
16%
Central Nucleus of the Amygdala
100%
Clonidine
16%
Corticotropin-Releasing Hormone
16%
Dysphoria
100%
Mecamylamine
50%
Nicotinic Acetylcholine Receptor
16%
Prazosin
16%
Receptor
100%
Receptor Antagonist
66%
Sigma 1 Opiate Receptor
16%
Sympathomimetic Drug
16%
Tobacco Dependence
16%
Withdrawal Syndrome
16%